FDA Inspection 995724 — Kyle Patrick, DO
The FDA completed an inspection of Kyle Patrick, DO on Dec 15, 2016 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 15, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Phoenix, AZ (United States)
Additional Details
Clinical Investigator (CI)